Articles

Through the acquisition, Element will have access to Avomeen’s expertise in formulation chemistry, product manufacturing, extractables and leachables, and large molecule testing.

Element Materials Technology to Expand its North American Presence with Avomeen Acquisition

As demand for COVID-19 vaccines increases, Big Pharma offers its manufacturing capacity and expertise.

Big Pharma Takes on Vaccine Production

Scientists at the company learned that deagglomeration techniques lose efficacy through equipment wear over time and developed a tactic that makes up for the wear and prepares an ideal sample for each particle size test. 

Hovione Technology Granted Patent for Deagglomeration Method

Both companies will provide resources and expertise to research, develop, and manufacture multiple mRNA vaccine candidates, including multi-valent and monovalent approaches. 

GSK and CureVac to Collaborate on Next-Generation COVID-19 Vaccines

The companies have entered into a research collaboration and license agreement for the potential treatment of rheumatoid arthritis via Imcyse’s RA program based on its Imotope technology.

Pfizer to Partner with Imcyse for Potential Rheumatoid Arthritis Treatment

More work is needed to educate businesses on the value of innovation and the availability of funding.

Continued Innovation is Key for COVID-19 Recovery

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA puts applications on hold as the agency limits alternative oversight methods. 

FDA Inspection Shutdown Increasingly Delays Approvals

The new board will join the company’s co-founder and chairman, Jay Walker, and company CEO, Franco Negron. 

ApiJect Appoints New Leadership Advisory Board

The companies previously entered into a collaboration in November 2020 with the goal of producing more than 100 million doses of the CureVac vaccine per year at Rentschler’s Laupheim, Germany facility.

CureVac and Rentschler Accelerate COVID-19 Vaccine Manufacturing

WuXi STA will acquire the site’s operations and assets, including the plant, equipment, and workforce.

News